A Split Body Study of the Effects of Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo
Phase of Trial: Phase II
Latest Information Update: 03 Sep 2019
Price : $35 *
At a glance
- Drugs Apremilast (Primary)
- Indications Vitiligo
- Focus Therapeutic Use
- 23 Aug 2019 Status changed from active, no longer recruiting to completed.
- 25 Mar 2019 Status changed from recruiting to active, no longer recruiting.
- 12 Sep 2018 Planned End Date changed from 1 Jun 2019 to 1 Aug 2019.